What is the Projected CAGR value of the Syndromic Multiplex Diagnostic Market?
The Syndromic Multiplex Diagnostic Market is expected to grow at a high CAGR of 7.3% during 2023-2030.
Who are the key players contributing to the growth of Syndromic Multiplex Diagnostic Market?
Some of the major key players in the global syndromic multiplex diagnostic market are Biomerieux SA, Luminex Corporation, QIAGEN, Applied BioCode, Akonni Biosystems, Abbott Diagnostics,